Sarcoma / 2013 / Article / Fig 1

Clinical Study

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

Figure 1

Median PFS: 4.2 months (95% CI: 2.0–6.3). PFS rate at 1 year: 19.2%. Median followup: 6.7 months.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.